focus -WSS

focus

author：focus 2025-09-28 23:31:45 - browse：58416

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Maker of FluMist seeks to allow at

WSS

FDA has safety concerns on CRISPR

American taxpayers paid $1.8 trillion in health care costs in 2022

Maker of FluMist seeks to allow at

Study suggests new cause of Down syndrome: cells linked to aging

Physician subsidies by hospitals soar in wake of No Surprises Act

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Medical records are filled with copy

JPM pitch from hospitals? Revenue streams outside of patient care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Telehealth options flood the market as retailers push virtual care

How one medical school became remarkably diverse

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Cancer drug shortages should be causing more outrage

First Opinion Podcast: How to protect health care in times of war

At least 13 dead in Texas as scorching temps continue

WHO may add ‘noma' to its list of neglected tropical diseases

explore

Eli Lilly to pay $200M for Beam’s stake in gene

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Stories you might have missed in 2023: health, science, medicine

The pink breast cancer awareness ribbon needs a redesign

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

American taxpayers paid $1.8 trillion in health care costs in 2022

hotspot

explore

leisure time

entertainment